Drugs / ILEPATRIL
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00284128 | Dec 2005 → Mar 2008 | hypertensive disorder | Sanofi | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ILEPATRIL | ChEMBL registry synonym — accepted as the source's own label CHEMBL3187812 ↗ |
| Known as | AVE7688 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00284128 ↗ |
| Known as | Ilepatrilo | ChEMBL registry synonym — accepted as the source's own label CHEMBL3187812 ↗ |
| Action | Inhibit | “Angiotensin-converting enzyme inhibitor” CHEMBL3187812 ↗1“Neprilysin inhibitor” CHEMBL3187812 ↗ |
| Modality | Small molecule | — CHEMBL3187812 ↗ |
| Route | Oral | “AVE7688 oral administration” NCT00284128 ↗ |
| Target | ACE | “Angiotensin-converting enzyme inhibitor” CHEMBL3187812 ↗ |
| Target | MME | “Neprilysin inhibitor” CHEMBL3187812 ↗ |